These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast. Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F; Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945 [TBL] [Abstract][Full Text] [Related]
4. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment. Noguera A; Fortuny C; Sanchez E; Artuch R; Vilaseca MA; Muñoz-Almagro C; Pou J; Jiménez R Pediatr Infect Dis J; 2003 Sep; 22(9):778-82. PubMed ID: 14506367 [TBL] [Abstract][Full Text] [Related]
5. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission. Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984 [TBL] [Abstract][Full Text] [Related]
6. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue? Soler-Palacín P; Martín-Nalda A; Martínez-Gómez X; Melendo S; Riudor E; Arranz JA; Espiau M; Figueras C AIDS Res Hum Retroviruses; 2012 Aug; 28(8):752-8. PubMed ID: 22010980 [TBL] [Abstract][Full Text] [Related]
7. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086 [TBL] [Abstract][Full Text] [Related]
8. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Bolhaar MG; Karstaedt AS Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788 [TBL] [Abstract][Full Text] [Related]
9. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306 [TBL] [Abstract][Full Text] [Related]
10. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166 [TBL] [Abstract][Full Text] [Related]
11. Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study. Mussi-Pinhata MM; Rego MA; Freimanis L; Kakehasi FM; Machado DM; Cardoso EM; Read JS; Pediatr Infect Dis J; 2007 Nov; 26(11):1032-7. PubMed ID: 17984811 [TBL] [Abstract][Full Text] [Related]
12. Zidovudine administration during pregnancy and mitochondrial disease in the offspring. Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting. Manosuthi W; Prasithsirikul W; Chumpathat N; Suntisuklappon B; Athichathanabadi C; Chimsuntorn S; Sungkanuparph S Int J Infect Dis; 2008 Nov; 12(6):582-6. PubMed ID: 18337140 [TBL] [Abstract][Full Text] [Related]
14. Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants. Côté HC; Raboud J; Bitnun A; Alimenti A; Money DM; Maan E; Costei A; Gadawski I; Diong C; Read S; Shen S; Harrigan PR; Burdge DR; King SM; Forbes JC J Infect Dis; 2008 Sep; 198(6):851-9. PubMed ID: 18684095 [TBL] [Abstract][Full Text] [Related]
15. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion. Antoniou T; Weisdorf T; Gough K CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549 [TBL] [Abstract][Full Text] [Related]
17. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Bunders MJ; Bekker V; Scherpbier HJ; Boer K; Godfried M; Kuijpers TW Acta Paediatr; 2005 Nov; 94(11):1571-7. PubMed ID: 16303696 [TBL] [Abstract][Full Text] [Related]
18. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687 [TBL] [Abstract][Full Text] [Related]
20. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG; Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]